Ginkgo Bioworks Holdings (DNA) Equity Ratio (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has 7 years of Equity Ratio data on file, last reported at 0.43 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio fell 14.3% year-over-year to 0.43; the trailing twelve-month figure through Mar 2026 stood at 0.43 (down 14.3% YoY), and the FY2025 full-year result was 0.45, down 12.62% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.43, down from 0.45 in the prior quarter.
• Across five years, Equity Ratio topped out at 0.79 in Q2 2022 and bottomed at 0.43 in Q1 2026.
• The 5-year median for Equity Ratio is 0.62 (2023), against an average of 0.6.
• The widest annual swing landed in 2022, when Equity Ratio surged 282.47%; it then retreated 21.86% in 2024.
• A 5-year view of Equity Ratio shows it stood at 0.68 in 2022, then fell by 3.65% to 0.66 in 2023, then fell by 21.09% to 0.52 in 2024, then decreased by 12.62% to 0.45 in 2025, then declined by 5.56% to 0.43 in 2026.
• The last three Equity Ratio figures came in at 0.43 (Q1 2026), 0.45 (Q4 2025), and 0.47 (Q3 2025), per Business Quant data.

Peer Comparison